<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34209133</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2273</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu13072273</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is a devastating progressive neurodegenerative disease that affects motor neurons, leading to a relentless paralysis of skeletal muscles and eventual respiratory failure. Although a small percentage of patients may have a longer survival time (up to 10 years), in most cases, the median survival time is from 20 to 48 months. The pathogenesis and risk factors for ALS are still unclear: among the various aspects taken into consideration, metabolic abnormalities and nutritional factors have been the focus of recent interests. Although there are no consistent findings regarding prior type-2 diabetes, hypercholesterolemia and ALS incidence, abnormalities in lipid and glucose metabolism may be linked to disease progression, leading to a relatively longer survival (probably as a result of counteract malnutrition and cachexia in the advanced stages of the disease). Among potential dietary risk factors, a higher risk of ALS has been associated with an increased intake of glutamate, while the consumption of antioxidant and anti-inflammatory compounds, such as vitamin E, n-3 polyunsaturated fatty acids, and carotenoids, has been related to lower incidence. Poor nutritional status and weight loss in ALS resulting from poor oral intake, progressive muscle atrophy, and the potential hypermetabolic state have been associated with rapid disease progression. It seems important to routinely perform a nutritional assessment of ALS patients at the earliest referral: weight maintenance (if adequate) or gain (if underweight) is suggested from the scientific literature; evidence of improved diet quality (in terms of nutrients and limits for pro-inflammatory dietary factors) and glucose and lipid control is yet to be confirmed, but it is advised. Further research is warranted to better understand the role of nutrition and the underlying metabolic abnormalities in ALS, and their contribution to the pathogenic mechanisms leading to ALS initiation and progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7494-9057</Identifier><AffiliationInfo><Affiliation>Department G.F. Ingrassia, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosso</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3930-5285</Identifier><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieves</LastName><ForeName>Jeri W</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0001-8593-343X</Identifier><AffiliationInfo><Affiliation>Mailman School of Public Health and Institute of Human Nutrition, Columbia University, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangh&#xec;</LastName><ForeName>Aurora</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department G.F. Ingrassia, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Factor-Litvak</LastName><ForeName>Pam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Mailman School of Public Health and Institute of Human Nutrition, Columbia University, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitsumoto</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Eleanor and Lou Gehrig ALS Center, The Neurological Institute of New York Columbia University Medical Center, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="Y">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044342" MajorTopicYN="N">Malnutrition</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009752" MajorTopicYN="Y">Nutritional Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">comprehensive review</Keyword><Keyword MajorTopicYN="N">dietary factors</Keyword><Keyword MajorTopicYN="N">energy expenditure</Keyword><Keyword MajorTopicYN="N">glucose metabolism</Keyword><Keyword MajorTopicYN="N">lipid metabolism</Keyword><Keyword MajorTopicYN="N">malnutrition</Keyword><Keyword MajorTopicYN="N">metabolic disorders</Keyword><Keyword MajorTopicYN="N">neurons</Keyword><Keyword MajorTopicYN="N">obesity</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>1</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34209133</ArticleId><ArticleId IdType="pmc">PMC8308334</ArticleId><ArticleId IdType="doi">10.3390/nu13072273</ArticleId><ArticleId IdType="pii">nu13072273</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rio A., Ellis C., Shaw C., Willey E., Ampong M.A., Wijesekera L., Rittman T., Nigel Leigh P., Sidhu P.S., Al-Chalabi A. Nutritional Factors Associated with Survival Following Enteral Tube Feeding in Patients with Motor Neurone Disease. J. Hum. Nutr. Diet. 2010;23:408&#x2013;415. doi: 10.1111/j.1365-277X.2010.01057.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-277X.2010.01057.x</ArticleId><ArticleId IdType="pubmed">20487174</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Traynor B.J., Collins J., Simeone J.C., Goldstein L.A., White L.A. Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature. Neuroepidemiology. 2013;41:118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E., Chi&#xf2; A., Couratier P., Esteban J., Hardiman O., Logroscino G., Millul A., Mitchell D., Preux P.-M., Pupillo E., et al. The Epidemiology and Treatment of ALS: Focus on the Heterogeneity of the Disease and Critical Appraisal of Therapeutic Trials. Amyotroph. Lateral Scler. 2011;12:1&#x2013;10. doi: 10.3109/17482968.2010.502940.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.502940</ArticleId><ArticleId IdType="pmc">PMC3513399</ArticleId><ArticleId IdType="pubmed">20698807</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Al-Chalabi A. Clinical Genetics of Amyotrophic Lateral Sclerosis: What Do We Really Know? Nat. Rev. Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic Lateral Sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicklund M.P. Amyotrophic Lateral Sclerosis: Possible Role of Environmental Influences. Neurol. Clin. 2005;23:461&#x2013;484. doi: 10.1016/j.ncl.2004.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2004.12.016</ArticleId><ArticleId IdType="pubmed">15757793</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvucci E. The Human-Microbiome Superorganism and Its Modulation to Restore Health. Int. J. Food Sci. Nutr. 2019;70:781&#x2013;795. doi: 10.1080/09637486.2019.1580682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09637486.2019.1580682</ArticleId><ArticleId IdType="pubmed">30843443</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gioia D., Bozzi Cionci N., Baffoni L., Amoruso A., Pane M., Mogna L., Gagg&#xec;a F., Lucenti M.A., Bersano E., Cantello R., et al. A Prospective Longitudinal Study on the Microbiota Composition in Amyotrophic Lateral Sclerosis. BMC Med. 2020;18:153. doi: 10.1186/s12916-020-01607-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01607-9</ArticleId><ArticleId IdType="pmc">PMC7298784</ArticleId><ArticleId IdType="pubmed">32546239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic Lateral Sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R. Progress and New Frontiers in Biomarkers for Amyotrophic Lateral Sclerosis. Biomark. Med. 2018;12:693&#x2013;696. doi: 10.2217/bmm-2018-0149.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2018-0149</ArticleId><ArticleId IdType="pubmed">29856233</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Rouleau G.A., Ravits J., Cashman N.R. Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS) Cold Spring Harb. Perspect. Med. 2017;7 doi: 10.1101/cshperspect.a024117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024117</ArticleId><ArticleId IdType="pmc">PMC5538408</ArticleId><ArticleId IdType="pubmed">28003278</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Jackson C.E., Kasarskis E.J., England J.D., Forshew D., Johnston W., Kalra S., Katz J.S., Mitsumoto H., Rosenfeld J., et al. Practice Parameter Update: The Care of the Patient with Amyotrophic Lateral Sclerosis: Multidisciplinary Care, Symptom Management, and Cognitive/Behavioral Impairment (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1227&#x2013;1233. doi: 10.1212/WNL.0b013e3181bc01a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc01a4</ArticleId><ArticleId IdType="pmc">PMC2764728</ArticleId><ArticleId IdType="pubmed">19822873</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Group; Edaravone (MCI-186) ALS 19 Study Group Safety and Efficacy of Edaravone in Well Defined Patients with Amyotrophic Lateral Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbull J. Is Edaravone Harmful? (A Placebo Is Not a Control) Amyotroph. Lateral Scler. Front. Degener. 2018;19:477&#x2013;482. doi: 10.1080/21678421.2018.1517179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1517179</ArticleId><ArticleId IdType="pubmed">30373406</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbull J. Reappraisal of an ALS Trial: Unaccounted Procedural Risk. Lancet Neurol. 2020;19:717&#x2013;718. doi: 10.1016/S1474-4422(20)30265-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30265-9</ArticleId><ArticleId IdType="pubmed">32822626</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Anderson F., Brooks B.R., Mitsumoto H., Bradley W.G., Ringel S.P., ALS CARE Study Group Outcomes Research in Amyotrophic Lateral Sclerosis: Lessons Learned from the Amyotrophic Lateral Sclerosis Clinical Assessment, Research, and Education Database. Ann. Neurol. 2009;65(Suppl. S1):S24&#x2013;S28. doi: 10.1002/ana.21556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21556</ArticleId><ArticleId IdType="pubmed">19191307</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Brooks B.R., Swain-Eng R.J., Basner R.C., Carter G.T., Casey P., Cohen A.B., Dubinsky R., Forshew D., Jackson C.E., et al. Quality Improvement in Neurology: Amyotrophic Lateral Sclerosis Quality Measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology. 2013;81:2136&#x2013;2140. doi: 10.1212/01.wnl.0000437305.37850.f9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000437305.37850.f9</ArticleId><ArticleId IdType="pmc">PMC3863352</ArticleId><ArticleId IdType="pubmed">24271651</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Rosenberg J.A., Gelinas D.F., Mitsumoto H., Newman D., Sufit R., Borasio G.D., Bradley W.G., Bromberg M.B., Brooks B.R., et al. Practice Parameter: The Care of the Patient with Amyotrophic Lateral Sclerosis (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52:1311&#x2013;1323. doi: 10.1212/WNL.52.7.1311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.52.7.1311</ArticleId><ArticleId IdType="pubmed">10227612</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Veyrat-Durebex C., Bocca C., Patin F., Vourc&#x2019;h P., Kouassi Nzoughet J., Lenaers G., Andres C.R., Simard G., Corcia P., et al. Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS. Sci. Rep. 2017;7:17652. doi: 10.1038/s41598-017-17389-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17389-9</ArticleId><ArticleId IdType="pmc">PMC5732162</ArticleId><ArticleId IdType="pubmed">29247199</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Khalik J., Yutuc E., Crick P.J., Gustafsson J.-&#xc5;., Warner M., Roman G., Talbot K., Gray E., Griffiths W.J., Turner M.R., et al. Defective Cholesterol Metabolism in Amyotrophic Lateral Sclerosis. J. Lipid Res. 2017;58:267&#x2013;278. doi: 10.1194/jlr.P071639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.P071639</ArticleId><ArticleId IdType="pmc">PMC5234729</ArticleId><ArticleId IdType="pubmed">27811233</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Borges K. Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments. Front. Neurosci. 2016;10:611. doi: 10.3389/fnins.2016.00611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00611</ArticleId><ArticleId IdType="pmc">PMC5222822</ArticleId><ArticleId IdType="pubmed">28119559</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama Y., Shimizu T., Matsuda C., Haraguchi M., Hayashi K., Bokuda K., Nagao M., Kawata A., Ishikawa-Takata K., Isozaki E. Body Weight Variation Predicts Disease Progression after Invasive Ventilation in Amyotrophic Lateral Sclerosis. Sci. Rep. 2019;9:12262. doi: 10.1038/s41598-019-48831-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48831-9</ArticleId><ArticleId IdType="pmc">PMC6706382</ArticleId><ArticleId IdType="pubmed">31439899</ArticleId></ArticleIdList></Reference><Reference><Citation>Godos J., Currenti W., Angelino D., Mena P., Castellano S., Caraci F., Galvano F., Del Rio D., Ferri R., Grosso G. Diet and mental health: Review of the recent updates on molecular mechanisms. Antioxidants. 2020;9:346. doi: 10.3390/antiox9040346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9040346</ArticleId><ArticleId IdType="pmc">PMC7222344</ArticleId><ArticleId IdType="pubmed">32340112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellogg J., Bottman L., Arra E.J., Selkirk S.M., Kozlowski F. Nutrition Management Methods Effective in Increasing Weight, Survival Time and Functional Status in ALS Patients: A Systematic Review. Amyotroph. Lateral Scler. Front. Degener. 2018;19:7&#x2013;11. doi: 10.1080/21678421.2017.1360355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1360355</ArticleId><ArticleId IdType="pubmed">28799809</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Pradat P.-F., Ludolph A.C., Loeffler J.-P. Energy Metabolism in Amyotrophic Lateral Sclerosis. Lancet Neurol. 2011;10:75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell C.S., Hollinger S.K., Goswami S.D., Polak M.A., Lee R.H., Glass J.D. Antecedent Disease Is Less Prevalent in Amyotrophic Lateral Sclerosis. Neurodegener. Dis. 2015;15:109&#x2013;113. doi: 10.1159/000369812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369812</ArticleId><ArticleId IdType="pmc">PMC4417009</ArticleId><ArticleId IdType="pubmed">25720304</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes E.T., Perurena O.H., Festoff B.W., Jorgensen R., Moore W.V. Insulin Resistance in Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 1984;63:317&#x2013;324. doi: 10.1016/0022-510X(84)90154-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(84)90154-0</ArticleId><ArticleId IdType="pubmed">6374040</ArticleId></ArticleIdList></Reference><Reference><Citation>Perurena O.H., Festoff B.W. Reduction in Insulin Receptors in Amyotrophic Lateral Sclerosis Correlates with Reduced Insulin Sensitivity. Neurology. 1987;37:1375&#x2013;1379. doi: 10.1212/WNL.37.8.1375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.37.8.1375</ArticleId><ArticleId IdType="pubmed">3614662</ArticleId></ArticleIdList></Reference><Reference><Citation>Harno K., Rissanen A., Palo J. Glucose Tolerance in Amyotrophic Lateral Sclerosis. Acta Neurol. Scand. 1984;70:451&#x2013;455. doi: 10.1111/j.1600-0404.1984.tb00851.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1984.tb00851.x</ArticleId><ArticleId IdType="pubmed">6516795</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A., Brown J.A., Schulz P.E. Diabetes Mellitus in Amyotrophic Lateral Sclerosis: Dr. Jekyll or Mr. Hyde? Eur. J. Neurol. 2015;22:1419&#x2013;1420. doi: 10.1111/ene.12660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12660</ArticleId><ArticleId IdType="pubmed">25597340</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowie C.C., Rust K.F., Byrd-Holt D.D., Eberhardt M.S., Flegal K.M., Engelgau M.M., Saydah S.H., Williams D.E., Geiss L.S., Gregg E.W. Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population: National Health And Nutrition Examination Survey 1999&#x2013;2002. Diabetes Care. 2006;29:1263&#x2013;1268. doi: 10.2337/dc06-0062.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc06-0062</ArticleId><ArticleId IdType="pubmed">16732006</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D., Hammar N., Malmstr&#xf6;m H., Ingre C., Jungner I., Ye W., Fang F., Walldius G. Blood Biomarkers of Carbohydrate, Lipid, and Apolipoprotein Metabolisms and Risk of Amyotrophic Lateral Sclerosis: A More than 20-Year Follow-up of the Swedish AMORIS Cohort. Ann. Neurol. 2017;81:718&#x2013;728. doi: 10.1002/ana.24936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24936</ArticleId><ArticleId IdType="pubmed">28437840</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A., Salamone A.R., Strutt A.M., Murthy S.B., Wheaton M., McDowell E.J., Simpson E., Appel S.H., York M.K., Schulz P.E. ALS Disease Onset May Occur Later in Patients with Pre-Morbid Diabetes Mellitus. Eur. J. Neurol. 2010;17:733&#x2013;739. doi: 10.1111/j.1468-1331.2009.02923.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02923.x</ArticleId><ArticleId IdType="pubmed">20074230</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ovidio F., d&#x2019;Errico A., Carn&#xe0; P., Calvo A., Costa G., Chi&#xf2; A. The Role of Pre-Morbid Diabetes on Developing Amyotrophic Lateral Sclerosis. Eur. J. Neurol. 2018;25:164&#x2013;170. doi: 10.1111/ene.13465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13465</ArticleId><ArticleId IdType="pubmed">28921834</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumacher J., Peter R.S., Nagel G., Rothenbacher D., Rosenbohm A., Ludolph A.C., Dorst J., ALS Registry Swabia Study Group Statins Diabetes Mellitus and Prognosis of Amyotrophic Lateral Sclerosis: Data from 501 Patients of a Population-Based Registry in Southwest Germany. Eur. J. Neurol. 2020;27:1405&#x2013;1414. doi: 10.1111/ene.14300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14300</ArticleId><ArticleId IdType="pubmed">32396653</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Hyman T., Shui A., Allred P., Harms M., Liu J., Maragakis N., Schoenfeld D., Yu H., Atassi N., et al. Pre-Morbid Type 2 Diabetes Mellitus Is Not a Prognostic Factor in Amyotrophic Lateral Sclerosis. Muscle Nerve. 2015;52:339&#x2013;343. doi: 10.1002/mus.24688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24688</ArticleId><ArticleId IdType="pmc">PMC4536144</ArticleId><ArticleId IdType="pubmed">25900666</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Lu C.-J., Chen R.-C., Hou W.-H., Li C.-Y. Risk of Amyotrophic Lateral Sclerosis in Patients with Diabetes: A Nationwide Population-Based Cohort Study. J. Epidemiol. 2015;25:445&#x2013;451. doi: 10.2188/jea.JE20140176.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20140176</ArticleId><ArticleId IdType="pmc">PMC4444499</ArticleId><ArticleId IdType="pubmed">25947580</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q.-Q., Chen Y., Cao B., Ou R.W., Zhang L., Hou Y., Gao X., Shang H. Blood Hemoglobin A1c Levels and Amyotrophic Lateral Sclerosis Survival. Mol. Neurodegener. 2017;12:69. doi: 10.1186/s13024-017-0211-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0211-y</ArticleId><ArticleId IdType="pmc">PMC5609007</ArticleId><ArticleId IdType="pubmed">28934974</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D., Kamel F., Bellocco R., Ye W., Fang F. Association between Diabetes and Amyotrophic Lateral Sclerosis in Sweden. Eur. J. Neurol. 2015;22:1436&#x2013;1442. doi: 10.1111/ene.12632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12632</ArticleId><ArticleId IdType="pmc">PMC4506907</ArticleId><ArticleId IdType="pubmed">25600257</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A., Paganoni S., Hauser C., Schulz P.E. Trials of Antidiabetic Drugs in Amyotrophic Lateral Sclerosis: Proceed with Caution? Neurodegener. Dis. 2014;13:205&#x2013;208. doi: 10.1159/000353158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000353158</ArticleId><ArticleId IdType="pmc">PMC4435550</ArticleId><ArticleId IdType="pubmed">24107404</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L., Schlagowski A., Ngo S.T., Vernay A., Dirrig-Grosch S., Henriques A., Boutillier A.-L., Zoll J., Echaniz-Laguna A., Loeffler J.-P., et al. A Metabolic Switch toward Lipid Use in Glycolytic Muscle Is an Early Pathologic Event in a Mouse Model of Amyotrophic Lateral Sclerosis. EMBO Mol. Med. 2015;7:526&#x2013;546. doi: 10.15252/emmm.201404433.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki K., Masamoto K., Morimoto N., Kurata T., Mimoto T., Obata T., Kanno I., Abe K. Early and Progressive Impairment of Spinal Blood Flow-Glucose Metabolism Coupling in Motor Neuron Degeneration of ALS Model Mice. J. Cereb. Blood Flow Metab. 2012;32:456&#x2013;467. doi: 10.1038/jcbfm.2011.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2011.155</ArticleId><ArticleId IdType="pmc">PMC3293114</ArticleId><ArticleId IdType="pubmed">22068226</ArticleId></ArticleIdList></Reference><Reference><Citation>Cistaro A., Pagani M., Montuschi A., Calvo A., Moglia C., Canosa A., Restagno G., Brunetti M., Traynor B.J., Nobili F., et al. The Metabolic Signature of C9ORF72-Related ALS: FDG PET Comparison with Nonmutated Patients. Eur. J. Nucl. Med. Mol. Imaging. 2014;41:844&#x2013;852. doi: 10.1007/s00259-013-2667-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-013-2667-5</ArticleId><ArticleId IdType="pubmed">24445987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A., Coccurello R. What Is &#x201c;Hyper&#x201d; in the ALS Hypermetabolism? Mediat. Inflamm. 2017;2017:7821672. doi: 10.1155/2017/7821672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7821672</ArticleId><ArticleId IdType="pmc">PMC5610793</ArticleId><ArticleId IdType="pubmed">29081604</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang B.L. Glucose, Glycolysis, and Neurodegenerative Diseases. J. Cell. Physiol. 2020;235:7653&#x2013;7662. doi: 10.1002/jcp.29682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.29682</ArticleId><ArticleId IdType="pubmed">32239718</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P.-F., Bruneteau G., Gordon P.H., Dupuis L., Bonnefont-Rousselot D., Simon D., Salachas F., Corcia P., Frochot V., Lacorte J.-M., et al. Impaired Glucose Tolerance in Patients with Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. 2010;11:166&#x2013;171. doi: 10.3109/17482960902822960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902822960</ArticleId><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson A., St&#xf6;rtebecker P. Vascular and Metabolic Studies of Amyotrophic Lateral Sclerosis. II. Lipid and Carbohydrate Metabolism. Neurology. 1972;22:528&#x2013;536. doi: 10.1212/WNL.22.5.528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.22.5.528</ArticleId><ArticleId IdType="pubmed">4673450</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Corcia P., Fergani A., Gonzalez De Aguilar J.L., Bonnefont-Rousselot D., Bittar R., Seilhean D., Hauw J.J., Lacomblez L., Loeffler J.P., et al. Dyslipidemia Is a Protective Factor in Amyotrophic Lateral Sclerosis. Neurology. 2008;70:1004&#x2013;1009. doi: 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Calvo A., Ilardi A., Cavallo E., Moglia C., Mutani R., Palmo A., Galletti R., Marinou K., Papetti L., et al. Lower Serum Lipid Levels Are Related to Respiratory Impairment in Patients with ALS. Neurology. 2009;73:1681&#x2013;1685. doi: 10.1212/WNL.0b013e3181c1df1e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181c1df1e</ArticleId><ArticleId IdType="pubmed">19917991</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J., K&#xfc;hnlein P., Hendrich C., Kassubek J., Sperfeld A.D., Ludolph A.C. Patients with Elevated Triglyceride and Cholesterol Serum Levels Have a Prolonged Survival in Amyotrophic Lateral Sclerosis. J. Neurol. 2011;258:613&#x2013;617. doi: 10.1007/s00415-010-5805-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5805-z</ArticleId><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutedja N.A., van der Schouw Y.T., Fischer K., Sizoo E.M., Huisman M.H.B., Veldink J.H., Van den Berg L.H. Beneficial Vascular Risk Profile Is Associated with Amyotrophic Lateral Sclerosis. J. Neurol. Neurosurg. Psychiatry. 2011;82:638&#x2013;642. doi: 10.1136/jnnp.2010.236752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.236752</ArticleId><ArticleId IdType="pubmed">21471184</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Deng J., Jaffa M., Cudkowicz M.E., Wills A.-M. Body Mass Index, Not Dyslipidemia, Is an Independent Predictor of Survival in Amyotrophic Lateral Sclerosis. Muscle Nerve. 2011;44:20&#x2013;24. doi: 10.1002/mus.22114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22114</ArticleId><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda K., Hirayama T., Takazawa T., Kawabe K., Iwasaki Y. Relationships between Disease Progression and Serum Levels of Lipid, Urate, Creatinine and Ferritin in Japanese Patients with Amyotrophic Lateral Sclerosis: A Cross-Sectional Study. Intern. Med. 2012;51:1501&#x2013;1508. doi: 10.2169/internalmedicine.51.7465.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.51.7465</ArticleId><ArticleId IdType="pubmed">22728481</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedic S.I.K., Stevic Z., Dedic V., Stojanovic V.R., Milicev M., Lavrnic D. Is Hyperlipidemia Correlated with Longer Survival in Patients with Amyotrophic Lateral Sclerosis? Neurol. Res. 2012;34:576&#x2013;580. doi: 10.1179/1743132812Y.0000000049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1743132812Y.0000000049</ArticleId><ArticleId IdType="pubmed">22732100</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.W., Kim S.-M., Kim H.-J., Kim J.-E., Park K.S., Kim S.-H., Lee K.-W., Sung J.-J. Hypolipidemia in Patients with Amyotrophic Lateral Sclerosis: A Possible Gender Difference? J. Clin. Neurol. 2013;9:125&#x2013;129. doi: 10.3988/jcn.2013.9.2.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2013.9.2.125</ArticleId><ArticleId IdType="pmc">PMC3633190</ArticleId><ArticleId IdType="pubmed">23626651</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang R., Guo X., Chen X., Zheng Z., Wei Q., Cao B., Zeng Y., Shang H. The Serum Lipid Profiles of Amyotrophic Lateral Sclerosis Patients: A Study from South-West China and a Meta-Analysis. Amyotroph. Lateral Scler. Front. Degener. 2015;16:359&#x2013;365. doi: 10.3109/21678421.2015.1047454.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1047454</ArticleId><ArticleId IdType="pubmed">26121273</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., Rosi E., Fini N., Fasano A., Raggi S., Fantuzzi A.L., Bedogni G. Changes in Routine Laboratory Tests and Survival in Amyotrophic Lateral Sclerosis. Neurol. Sci. 2017;38:2177&#x2013;2182. doi: 10.1007/s10072-017-3138-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-017-3138-8</ArticleId><ArticleId IdType="pubmed">28980128</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaye J.B., Patin F., Piver E., Bruno C., Vasse M., Vourc&#x2019;h P., Andres C.R., Corcia P., Blasco H. Low IDL-B and High LDL-1 Subfraction Levels in Serum of ALS Patients. J. Neurol. Sci. 2017;380:124&#x2013;127. doi: 10.1016/j.jns.2017.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.07.019</ArticleId><ArticleId IdType="pubmed">28870551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C., Chen L., Zhan Y., Termorshuizen J., Yin L., Fang F. Lipids, Apolipoproteins, and Prognosis of Amyotrophic Lateral Sclerosis. Neurology. 2020;94:e1835&#x2013;e1844. doi: 10.1212/WNL.0000000000009322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009322</ArticleId><ArticleId IdType="pmc">PMC7274849</ArticleId><ArticleId IdType="pubmed">32221024</ArticleId></ArticleIdList></Reference><Reference><Citation>Despr&#xe9;s J.P. Abdominal Obesity as Important Component of Insulin-Resistance Syndrome. Nutrition. 1993;9:452&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pubmed">8286886</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B., Desport J.C., Kajeu P., Jesus P., Nicolaud B., Nicol M., Preux P.M., Couratier P. Alteration of Nutritional Status at Diagnosis Is a Prognostic Factor for Survival of Amyotrophic Lateral Sclerosis Patients. J. Neurol. Neurosurg. Psychiatry. 2011;82:628&#x2013;634. doi: 10.1136/jnnp.2010.211474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.211474</ArticleId><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport J.C., Preux P.M., Bouteloup-Demange C., Clavelou P., Beaufr&#xe8;re B., Bonnet C., Couratier P.P. Validation of Bioelectrical Impedance Analysis in Patients with Amyotrophic Lateral Sclerosis. Am. J. Clin. Nutr. 2003;77:1179&#x2013;1185. doi: 10.1093/ajcn/77.5.1179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/77.5.1179</ArticleId><ArticleId IdType="pubmed">12716669</ArticleId></ArticleIdList></Reference><Reference><Citation>Roubeau V., Blasco H., Maillot F., Corcia P., Praline J. Nutritional Assessment of Amyotrophic Lateral Sclerosis in Routine Practice: Value of Weighing and Bioelectrical Impedance Analysis. Muscle Nerve. 2015;51:479&#x2013;484. doi: 10.1002/mus.24419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24419</ArticleId><ArticleId IdType="pubmed">25130859</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindauer E., Dupuis L., M&#xfc;ller H.-P., Neumann H., Ludolph A.C., Kassubek J. Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis. PLoS ONE. 2013;8:e67783. doi: 10.1371/journal.pone.0067783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067783</ArticleId><ArticleId IdType="pmc">PMC3694869</ArticleId><ArticleId IdType="pubmed">23826340</ArticleId></ArticleIdList></Reference><Reference><Citation>Newhouse A., Chemali Z. Neuroendocrine Disturbances in Neurodegenerative Disorders: A Scoping Review. Psychosomatics. 2020;61:105&#x2013;115. doi: 10.1016/j.psym.2019.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psym.2019.11.002</ArticleId><ArticleId IdType="pubmed">31918850</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A., Abid A., Schulz P.E. Diabetes Mellitus and Amyotrophic Lateral Sclerosis: Time to Bridge the Gap between the Bench and the Bedside. Eur. J. Neurol. 2018;25:3&#x2013;4. doi: 10.1111/ene.13481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13481</ArticleId><ArticleId IdType="pubmed">29044904</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Monte S.M. Insulin Resistance and Neurodegeneration: Progress towards the Development of New Therapeutics for Alzheimer&#x2019;s Disease. Drugs. 2017;77:47&#x2013;65. doi: 10.1007/s40265-016-0674-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-016-0674-0</ArticleId><ArticleId IdType="pmc">PMC5575843</ArticleId><ArticleId IdType="pubmed">27988872</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan D.M., Davidson M.B., DeFronzo R.A., Heine R.J., Henry R.R., Pratley R., Zinman B., American Diabetes Association Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for Care. Diabetes Care. 2007;30:753&#x2013;759. doi: 10.2337/dc07-9920.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc07-9920</ArticleId><ArticleId IdType="pubmed">17327355</ArticleId></ArticleIdList></Reference><Reference><Citation>Norhammar A., Tenerz A., Nilsson G., Hamsten A., Efend&#xed;c S., Ryd&#xe9;n L., Malmberg K. Glucose Metabolism in Patients with Acute Myocardial Infarction and No Previous Diagnosis of Diabetes Mellitus: A Prospective Study. Lancet. 2002;359:2140&#x2013;2144. doi: 10.1016/S0140-6736(02)09089-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)09089-X</ArticleId><ArticleId IdType="pubmed">12090978</ArticleId></ArticleIdList></Reference><Reference><Citation>Adibhatla R.M., Hatcher J.F. Role of Lipids in Brain Injury and Diseases. Future Lipidol. 2007;2:403&#x2013;422. doi: 10.2217/17460875.2.4.403.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/17460875.2.4.403</ArticleId><ArticleId IdType="pmc">PMC2174836</ArticleId><ArticleId IdType="pubmed">18176634</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt F., Hussain G., Dupuis L., Loeffler J.-P., Henriques A. A Plural Role for Lipids in Motor Neuron Diseases: Energy, Signaling and Structure. Front. Cell. Neurosci. 2014;8:25. doi: 10.3389/fncel.2014.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00025</ArticleId><ArticleId IdType="pmc">PMC3929843</ArticleId><ArticleId IdType="pubmed">24600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez De Aguilar J.-L. Lipid Biomarkers for Amyotrophic Lateral Sclerosis. Front. Neurol. 2019;10:284. doi: 10.3389/fneur.2019.00284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00284</ArticleId><ArticleId IdType="pmc">PMC6458258</ArticleId><ArticleId IdType="pubmed">31019485</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R., Kapogiannis D., Huey E.D., Momeni P. FTD and ALS: A Tale of Two Diseases. Curr. Alzheimer Res. 2011;8:273&#x2013;294. doi: 10.2174/156720511795563700.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720511795563700</ArticleId><ArticleId IdType="pmc">PMC3801195</ArticleId><ArticleId IdType="pubmed">21222600</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R.M., Highton-Williamson E., Caga J., Thornton N., Ramsey E., Zoing M., Kim W.S., Halliday G.M., Piguet O., Hodges J.R., et al. Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition. J. Alzheimers Dis. 2018;61:773&#x2013;783. doi: 10.3233/JAD-170660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170660</ArticleId><ArticleId IdType="pubmed">29254092</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K., O&#x2019;Reilly &#xc9;.J., Cortese M., Furtado J.D., Kolonel L.N., Le Marchand L., Mccullough M.L., Paganoni S., Schwarzschild M.A., Shadyab A.H., et al. Pre-Diagnostic Plasma Lipid Levels and the Risk of Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2021;22:133&#x2013;143. doi: 10.1080/21678421.2020.1822411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1822411</ArticleId><ArticleId IdType="pmc">PMC8004541</ArticleId><ArticleId IdType="pubmed">32985910</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein M.R., Mascitelli L., Pezzetta F. Dyslipidemia Is a Protective Factor in Amyotrophic Lateral Sclerosis. Neurology. 2008;71:956&#x2013;957. doi: 10.1212/01.wnl.0000327866.54482.f1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000327866.54482.f1</ArticleId><ArticleId IdType="pubmed">18794503</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii Y., Ikeda K., Iwamoto K., Kawase Y., Iwasaki Y. Re: Dyslipidemia Is a Protective Factor in Amyotrophic Lateral Sclerosis. Neurology. 2009;72:944&#x2013;945. doi: 10.1212/01.wnl.0000339397.79460.d5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000339397.79460.d5</ArticleId><ArticleId IdType="pubmed">19273834</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiq M.K., Lee E., Bradburn M., McDermott C.J., Shaw P.J. Effect of Lipid Profile on Prognosis in the Patients with Amyotrophic Lateral Sclerosis: Insights from the Olesoxime Clinical Trial. Amyotroph. Lateral Scler. Front. Degener. 2015;16:1&#x2013;7. doi: 10.3109/21678421.2015.1062517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1062517</ArticleId><ArticleId IdType="pubmed">26161993</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy L.M., Chapman A.L., Shaw P.J., Grierson A.J. Review: The Role of Mitochondria in the Pathogenesis of Amyotrophic Lateral Sclerosis. Neuropathol. Appl. Neurobiol. 2011;37:336&#x2013;352. doi: 10.1111/j.1365-2990.2011.01166.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2011.01166.x</ArticleId><ArticleId IdType="pubmed">21299590</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredi G., Kawamata H. Mitochondria and Endoplasmic Reticulum Crosstalk in Amyotrophic Lateral Sclerosis. Neurobiol. Dis. 2016;90:35&#x2013;42. doi: 10.1016/j.nbd.2015.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.08.004</ArticleId><ArticleId IdType="pmc">PMC4754163</ArticleId><ArticleId IdType="pubmed">26282323</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The Role of Mitochondria in Amyotrophic Lateral Sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano Y., Hirayama K., Terao K. Hepatic Ultrastructural Changes and Liver Dysfunction in Amyotrophic Lateral Sclerosis. Arch. Neurol. 1987;44:103&#x2013;106. doi: 10.1001/archneur.1987.00520130079022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1987.00520130079022</ArticleId><ArticleId IdType="pubmed">3800708</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;jlund K., Mogensen M., Sahlin K., Beck-Nielsen H. Mitochondrial Dysfunction in Type 2 Diabetes and Obesity. Endocrinol. Metab. Clin. N. Am. 2008;37:713&#x2013;731. doi: 10.1016/j.ecl.2008.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecl.2008.06.006</ArticleId><ArticleId IdType="pubmed">18775360</ArticleId></ArticleIdList></Reference><Reference><Citation>Joardar A., Manzo E., Zarnescu D.C. Metabolic Dysregulation in Amyotrophic Lateral Sclerosis: Challenges and Opportunities. Curr. Genet. Med. Rep. 2017;5:108&#x2013;114. doi: 10.1007/s40142-017-0123-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40142-017-0123-8</ArticleId><ArticleId IdType="pmc">PMC5647833</ArticleId><ArticleId IdType="pubmed">29057168</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuttall F.Q. Body Mass Index: Obesity, BMI, and Health: A Critical Review. Nutr. Today. 2015;50:117&#x2013;128. doi: 10.1097/NT.0000000000000092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NT.0000000000000092</ArticleId><ArticleId IdType="pmc">PMC4890841</ArticleId><ArticleId IdType="pubmed">27340299</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reilly &#xc9;.J., Wang M., Adami H.-O., Alonso A., Bernstein L., van den Brandt P., Buring J., Daugherty S., Deapen D., Freedman D.M., et al. Prediagnostic Body Size and Risk of Amyotrophic Lateral Sclerosis Death in 10 Studies. Amyotroph. Lateral Scler. Front. Degener. 2018;19:396&#x2013;406. doi: 10.1080/21678421.2018.1452944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1452944</ArticleId><ArticleId IdType="pmc">PMC6423444</ArticleId><ArticleId IdType="pubmed">29658324</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V., Wark P.A., Jenab M., Pearce N., Brayne C., Vermeulen R., Andersen P.M., Hallmans G., Kyrozis A., Vanacore N., et al. Prediagnostic Body Fat and Risk of Death from Amyotrophic Lateral Sclerosis: The EPIC Cohort. Neurology. 2013;80:829&#x2013;838. doi: 10.1212/WNL.0b013e3182840689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182840689</ArticleId><ArticleId IdType="pmc">PMC3598455</ArticleId><ArticleId IdType="pubmed">23390184</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reilly &#xc9;.J., Wang H., Weisskopf M.G., Fitzgerald K.C., Falcone G., McCullough M.L., Thun M., Park Y., Kolonel L.N., Ascherio A. Premorbid Body Mass Index and Risk of Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2013;14:205&#x2013;211. doi: 10.3109/21678421.2012.735240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.735240</ArticleId><ArticleId IdType="pmc">PMC3615420</ArticleId><ArticleId IdType="pubmed">23134505</ArticleId></ArticleIdList></Reference><Reference><Citation>Riboli E., Hunt K.J., Slimani N., Ferrari P., Norat T., Fahey M., Charrondi&#xe8;re U.R., H&#xe9;mon B., Casagrande C., Vignat J., et al. European Prospective Investigation into Cancer and Nutrition (EPIC): Study Populations and Data Collection. Public Health Nutr. 2002;5:1113&#x2013;1124. doi: 10.1079/PHN2002394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1079/PHN2002394</ArticleId><ArticleId IdType="pubmed">12639222</ArticleId></ArticleIdList></Reference><Reference><Citation>Maselli R.A., Wollman R.L., Leung C., Distad B., Palombi S., Richman D.P., Salazar-Grueso E.F., Roos R.P. Neuromuscular Transmission in Amyotrophic Lateral Sclerosis. Muscle Nerve. 1993;16:1193&#x2013;1203. doi: 10.1002/mus.880161109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880161109</ArticleId><ArticleId IdType="pubmed">8105377</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hnlein P., Gdynia H.-J., Sperfeld A.-D., Lindner-Pfleghar B., Ludolph A.C., Prosiegel M., Riecker A. Diagnosis and Treatment of Bulbar Symptoms in Amyotrophic Lateral Sclerosis. Nat. Clin. Pract. Neurol. 2008;4:366&#x2013;374. doi: 10.1038/ncpneuro0853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpneuro0853</ArticleId><ArticleId IdType="pubmed">18560390</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo S.T., Steyn F.J., McCombe P.A. Body Mass Index and Dietary Intervention: Implications for Prognosis of Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 2014;340:5&#x2013;12. doi: 10.1016/j.jns.2014.02.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.02.035</ArticleId><ArticleId IdType="pubmed">24629478</ArticleId></ArticleIdList></Reference><Reference><Citation>Janse van Mantgem M.R., van Eijk R.P.A., van der Burgh H.K., Tan H.H.G., Westeneng H.-J., van Es M.A., Veldink J.H., van den Berg L.H. Prognostic Value of Weight Loss in Patients with Amyotrophic Lateral Sclerosis: A Population-Based Study. J. Neurol. Neurosurg. Psychiatry. 2020;91:867&#x2013;875. doi: 10.1136/jnnp-2020-322909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-322909</ArticleId><ArticleId IdType="pubmed">32576612</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerterp K.R. Diet Induced Thermogenesis. Nutr. Metab. 2004;1:5. doi: 10.1186/1743-7075-1-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-7075-1-5</ArticleId><ArticleId IdType="pmc">PMC524030</ArticleId><ArticleId IdType="pubmed">15507147</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasarskis E.J., Mendiondo M.S., Matthews D.E., Mitsumoto H., Tandan R., Simmons Z., Bromberg M.B., Kryscio R.J., ALS Nutrition/NIPPV Study Group Estimating Daily Energy Expenditure in Individuals with Amyotrophic Lateral Sclerosis. Am. J. Clin. Nutr. 2014;99:792&#x2013;803. doi: 10.3945/ajcn.113.069997.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.113.069997</ArticleId><ArticleId IdType="pmc">PMC3953880</ArticleId><ArticleId IdType="pubmed">24522445</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankenfield D.C., Muth E.R., Rowe W.A. The Harris-Benedict Studies of Human Basal Metabolism. J. Am. Diet. Assoc. 1998;98:439&#x2013;445. doi: 10.1016/S0002-8223(98)00100-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-8223(98)00100-X</ArticleId><ArticleId IdType="pubmed">9550168</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaisman N., Lusaus M., Nefussy B., Niv E., Comaneshter D., Hallack R., Drory V.E. Do Patients with Amyotrophic Lateral Sclerosis (ALS) Have Increased Energy Needs? J. Neurol. Sci. 2009;279:26&#x2013;29. doi: 10.1016/j.jns.2008.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.12.027</ArticleId><ArticleId IdType="pubmed">19185883</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport J.C., Preux P.M., Truong C.T., Courat L., Vallat J.M., Couratier P. Nutritional Assessment and Survival in ALS Patients. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:91&#x2013;96. doi: 10.1080/14660820050515386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820050515386</ArticleId><ArticleId IdType="pubmed">11467055</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasarskis E.J., Berryman S., Vanderleest J.G., Schneider A.R., McClain C.J. Nutritional Status of Patients with Amyotrophic Lateral Sclerosis: Relation to the Proximity of Death. Am. J. Clin. Nutr. 1996;63:130&#x2013;137. doi: 10.1093/ajcn/63.1.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/63.1.130</ArticleId><ArticleId IdType="pubmed">8604660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis A.C., Rosenfeld J. Which Equation Best Predicts Energy Expenditure in Amyotrophic Lateral Sclerosis? J. Am. Diet. Assoc. 2011;111:1680&#x2013;1687. doi: 10.1016/j.jada.2011.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jada.2011.08.002</ArticleId><ArticleId IdType="pubmed">22027050</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman M.S., Pillai A., Jackson A., Heiman-Patterson T. Standard Equations Are Not Accurate in Assessing Resting Energy Expenditure in Patients with Amyotrophic Lateral Sclerosis. JPEN J. Parenter. Enter. Nutr. 2004;28:442&#x2013;446. doi: 10.1177/0148607104028006442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607104028006442</ArticleId><ArticleId IdType="pubmed">15568293</ArticleId></ArticleIdList></Reference><Reference><Citation>Genton L., Viatte V., Janssens J.P., H&#xe9;ritier A.C., Pichard C. Nutritional State, Energy Intakes and Energy Expenditure of Amyotrophic Lateral Sclerosis (ALS) Patients. Clin. Nutr. 2011;30:553&#x2013;559. doi: 10.1016/j.clnu.2011.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2011.06.004</ArticleId><ArticleId IdType="pubmed">21798636</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport J.C., Preux P.M., Magy L., Boirie Y., Vallat J.M., Beaufr&#xe8;re B., Couratier P. Factors Correlated with Hypermetabolism in Patients with Amyotrophic Lateral Sclerosis. Am. J. Clin. Nutr. 2001;74:328&#x2013;334. doi: 10.1093/ajcn/74.3.328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/74.3.328</ArticleId><ArticleId IdType="pubmed">11522556</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport J.-C., Torny F., Lacoste M., Preux P.-M., Couratier P. Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters. Neurodegener. Dis. 2005;2:202&#x2013;207. doi: 10.1159/000089626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089626</ArticleId><ArticleId IdType="pubmed">16909026</ArticleId></ArticleIdList></Reference><Reference><Citation>Funalot B., Desport J.-C., Sturtz F., Camu W., Couratier P. High Metabolic Level in Patients with Familial Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. 2009;10:113&#x2013;117. doi: 10.1080/17482960802295192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802295192</ArticleId><ArticleId IdType="pubmed">18792852</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y., Park J., Kim Y., Baek H., Kim S.H. Association between Nutritional Status and Disease Severity Using the Amyotrophic Lateral Sclerosis (ALS) Functional Rating Scale in ALS Patients. Nutrition. 2015;31:1362&#x2013;1367. doi: 10.1016/j.nut.2015.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2015.05.025</ArticleId><ArticleId IdType="pubmed">26429656</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe9;sus P., Fayemendy P., Nicol M., Lautrette G., Sourisseau H., Preux P.M., Desport J.C., Marin B., Couratier P. Hypermetabolism Is a Deleterious Prognostic Factor in Patients with Amyotrophic Lateral Sclerosis. Eur. J. Neurol. 2018;25:97&#x2013;104. doi: 10.1111/ene.13468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13468</ArticleId><ArticleId IdType="pubmed">28940704</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Baek H., Kim S.H., Park Y. Association between Estimated Total Daily Energy Expenditure and Stage of Amyotrophic Lateral Sclerosis. Nutrition. 2017;33:181&#x2013;186. doi: 10.1016/j.nut.2016.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2016.06.007</ArticleId><ArticleId IdType="pubmed">27544003</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn F.J., Ioannides Z.A., van Eijk R.P.A., Heggie S., Thorpe K.A., Ceslis A., Heshmat S., Henders A.K., Wray N.R., van den Berg L.H., et al. Hypermetabolism in ALS Is Associated with Greater Functional Decline and Shorter Survival. J. Neurol. Neurosurg. Psychiatry. 2018;89:1016&#x2013;1023. doi: 10.1136/jnnp-2017-317887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C., Desport J.C., Clavelou P., Guy N., Derumeaux-Burel H., Ferrier A., Couratier P. Hypermetabolism in ALS Patients: An Early and Persistent Phenomenon. J. Neurol. 2009;256:1236&#x2013;1242. doi: 10.1007/s00415-009-5100-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachman E.S., Dhillon H., Zhang C.-Y., Cinti S., Bianco A.C., Kobilka B.K., Lowell B.B. BetaAR Signaling Required for Diet-Induced Thermogenesis and Obesity Resistance. Science. 2002;297:843&#x2013;845. doi: 10.1126/science.1073160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1073160</ArticleId><ArticleId IdType="pubmed">12161655</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltadzhieva R., Gurevich T., Korczyn A.D. Autonomic Impairment in Amyotrophic Lateral Sclerosis. Curr. Opin. Neurol. 2005;18:487&#x2013;493. doi: 10.1097/01.wco.0000183114.76056.0e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wco.0000183114.76056.0e</ArticleId><ArticleId IdType="pubmed">16155429</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscaritoli M., Kushta I., Molfino A., Inghilleri M., Sabatelli M., Rossi Fanelli F. Nutritional and Metabolic Support in Patients with Amyotrophic Lateral Sclerosis. Nutrition. 2012;28:959&#x2013;966. doi: 10.1016/j.nut.2012.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2012.01.011</ArticleId><ArticleId IdType="pubmed">22677356</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Oudart H., Ren&#xe9; F., Gonzalez de Aguilar J.-L., Loeffler J.-P. Evidence for Defective Energy Homeostasis in Amyotrophic Lateral Sclerosis: Benefit of a High-Energy Diet in a Transgenic Mouse Model. Proc. Natl. Acad. Sci. USA. 2004;101:11159&#x2013;11164. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Fergani A., Oudart H., Gonzalez De Aguilar J.-L., Fricker B., Ren&#xe9; F., Hocquette J.-F., Meininger V., Dupuis L., Loeffler J.-P. Increased Peripheral Lipid Clearance in an Animal Model of Amyotrophic Lateral Sclerosis. J. Lipid Res. 2007;48:1571&#x2013;1580. doi: 10.1194/jlr.M700017-JLR200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M700017-JLR200</ArticleId><ArticleId IdType="pmc">PMC1974855</ArticleId><ArticleId IdType="pubmed">17438338</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies F.M., Ince P.G., Shaw P.J. Mitochondrial Involvement in Amyotrophic Lateral Sclerosis. Neurochem. Int. 2002;40:543&#x2013;551. doi: 10.1016/S0197-0186(01)00125-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-0186(01)00125-5</ArticleId><ArticleId IdType="pubmed">11850111</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge J.C., Treleaven C.M., Fidler J.A., Tamsett T.J., Bao C., Searles M., Taksir T.V., Misra K., Sidman R.L., Cheng S.H., et al. Metabolic Signatures of Amyotrophic Lateral Sclerosis Reveal Insights into Disease Pathogenesis. Proc. Natl. Acad. Sci. USA. 2013;110:10812&#x2013;10817. doi: 10.1073/pnas.1308421110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1308421110</ArticleId><ArticleId IdType="pmc">PMC3696768</ArticleId><ArticleId IdType="pubmed">23754387</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad C., Kawamata H., Bredvik K.G., Arreguin A.J., Cajamarca S.A., Hupf J.C., Ravits J.M., Miller T.M., Maragakis N.J., Hales C.M., et al. Fibroblast Bioenergetics to Classify Amyotrophic Lateral Sclerosis Patients. Mol. Neurodegener. 2017;12:76. doi: 10.1186/s13024-017-0217-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0217-5</ArticleId><ArticleId IdType="pmc">PMC5655870</ArticleId><ArticleId IdType="pubmed">29065921</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk K., Gennings C., Hupf J.C., Tadesse S., D&#x2019;Aurelio M., Kawamata H., Valsecchi F., Mitsumoto H., ALS/PLS COSMOS Study Groups. Manfredi G. Bioenergetic Markers in Skin Fibroblasts of Sporadic Amyotrophic Lateral Sclerosis and Progressive Lateral Sclerosis Patients. Ann. Neurol. 2014;76:620&#x2013;624. doi: 10.1002/ana.24244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24244</ArticleId><ArticleId IdType="pmc">PMC4192005</ArticleId><ArticleId IdType="pubmed">25090982</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall W.J. Nutritional Assessment: Its Role in the Provision of Nutritional Support. J. Clin. Pathol. 2008;61:1083&#x2013;1088. doi: 10.1136/jcp.2007.051813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2007.051813</ArticleId><ArticleId IdType="pubmed">18818263</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans W.J., Morley J.E., Argil&#xe9;s J., Bales C., Baracos V., Guttridge D., Jatoi A., Kalantar-Zadeh K., Lochs H., Mantovani G., et al. Cachexia: A New Definition. Clin. Nutr. 2008;27:793&#x2013;799. doi: 10.1016/j.clnu.2008.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2008.06.013</ArticleId><ArticleId IdType="pubmed">18718696</ArticleId></ArticleIdList></Reference><Reference><Citation>Piquet M.A. Nutritional Approach for Patients with Amyotrophic Lateral Sclerosis. Rev. Neurol. 2006;162:4S177&#x2013;4S187. doi: 10.1016/S0035-3787(06)75183-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0035-3787(06)75183-9</ArticleId><ArticleId IdType="pubmed">17128108</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport J.C., Preux P.M., Truong T.C., Vallat J.M., Sautereau D., Couratier P. Nutritional Status Is a Prognostic Factor for Survival in ALS Patients. Neurology. 1999;53:1059&#x2013;1063. doi: 10.1212/WNL.53.5.1059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.53.5.1059</ArticleId><ArticleId IdType="pubmed">10496266</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A., Murthy S.B., Wilson A.M., Qureshi S.U., Amro M.J., Wheaton M., Simpson E., Harati Y., Strutt A.M., York M.K., et al. A Decrease in Body Mass Index Is Associated with Faster Progression of Motor Symptoms and Shorter Survival in ALS. Amyotroph. Lateral Scler. 2010;11:542&#x2013;548. doi: 10.3109/17482968.2010.482592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.482592</ArticleId><ArticleId IdType="pubmed">20500116</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B., Arcuti S., Jesus P., Logroscino G., Copetti M., Fontana A., Nicol M., Raymondeau M., Desport J.C., Preux P.M., et al. Population-Based Evidence That Survival in Amyotrophic Lateral Sclerosis Is Related to Weight Loss at Diagnosis. Neurodegener. Dis. 2016;16:225&#x2013;234. doi: 10.1159/000442444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000442444</ArticleId><ArticleId IdType="pubmed">26866503</ArticleId></ArticleIdList></Reference><Reference><Citation>Limousin N., Blasco H., Corcia P., Gordon P.H., De Toffol B., Andres C., Praline J. Malnutrition at the Time of Diagnosis Is Associated with a Shorter Disease Duration in ALS. J. Neurol. Sci. 2010;297:36&#x2013;39. doi: 10.1016/j.jns.2010.06.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.06.028</ArticleId><ArticleId IdType="pubmed">20673675</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesus P., Massoulard A., Marin B., Nicol M., Laplagne O., Baptiste A., Gindre-Poulvelarie L., Couratier P., Fraysse J.L., Desport J.C. First Assessment at Home of Amyotrophic Lateral Sclerosis (ALS) Patients by a Nutrition Network in the French Region of Limousin. Amyotroph. Lateral Scler. 2012;13:538&#x2013;543. doi: 10.3109/17482968.2012.701309.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.701309</ArticleId><ArticleId IdType="pubmed">22775117</ArticleId></ArticleIdList></Reference><Reference><Citation>Petzold G.C., Einh&#xe4;upl K.M., Valdueza J.M. Persistent Bitter Taste as an Initial Symptom of Amyotrophic Lateral Sclerosis. J. Neurol. Neurosurg. Psychiatr. 2003;74:687&#x2013;688. doi: 10.1136/jnnp.74.5.687-a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.74.5.687-a</ArticleId><ArticleId IdType="pmc">PMC1738429</ArticleId><ArticleId IdType="pubmed">12700324</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., van den Berg L.H., Kiernan M.C. Clinical Diagnosis and Management of Amyotrophic Lateral Sclerosis. Nat. Rev. Neurol. 2011;7:639&#x2013;649. doi: 10.1038/nrneurol.2011.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.153</ArticleId><ArticleId IdType="pubmed">21989247</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K.C., O&#x2019;Reilly &#xc9;.J., Falcone G.J., McCullough M.L., Park Y., Kolonel L.N., Ascherio A. Dietary &#x3c9;-3 Polyunsaturated Fatty Acid Intake and Risk for Amyotrophic Lateral Sclerosis. JAMA Neurol. 2014;71:1102&#x2013;1110. doi: 10.1001/jamaneurol.2014.1214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1214</ArticleId><ArticleId IdType="pmc">PMC4160351</ArticleId><ArticleId IdType="pubmed">25023276</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Li P., Hu X., Zhang F., Chen J., Gao Y. Omega-3 Polyunsaturated Fatty Acids in the Brain: Metabolism and Neuroprotection. Front. Biosci. 2011;16:2653&#x2013;2670. doi: 10.2741/3878.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/3878</ArticleId><ArticleId IdType="pubmed">21622201</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson L.M., Matkin C., Longstreth W.T., McGuire V. Population-Based Case-Control Study of Amyotrophic Lateral Sclerosis in Western Washington State. II. Diet. Am. J. Epidemiol. 2000;151:164&#x2013;173. doi: 10.1093/oxfordjournals.aje.a010184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a010184</ArticleId><ArticleId IdType="pubmed">10645819</ArticleId></ArticleIdList></Reference><Reference><Citation>Morozova N., Weisskopf M.G., McCullough M.L., Munger K.L., Calle E.E., Thun M.J., Ascherio A. Diet and Amyotrophic Lateral Sclerosis. Epidemiology. 2008;19:324&#x2013;337. doi: 10.1097/EDE.0b013e3181632c5d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181632c5d</ArticleId><ArticleId IdType="pubmed">18300717</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman M.H.B., Seelen M., van Doormaal P.T.C., de Jong S.W., de Vries J.H.M., van der Kooi A.J., de Visser M., Schelhaas H.J., van den Berg L.H., Veldink J.H. Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis. JAMA Neurol. 2015;72:1155&#x2013;1162. doi: 10.1001/jamaneurol.2015.1584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.1584</ArticleId><ArticleId IdType="pubmed">26280944</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo E., Bianchi E., Chi&#xf2; A., Casale F., Zecca C., Tortelli R., Beghi E., SLALOM Group. PARALS Group. SLAP Group Amyotrophic Lateral Sclerosis and Food Intake. Amyotroph. Lateral Scler. Front. Degener. 2018;19:267&#x2013;274. doi: 10.1080/21678421.2017.1418002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1418002</ArticleId><ArticleId IdType="pubmed">29268633</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto K., Kihira T., Kondo T., Kobashi G., Washio M., Sasaki S., Yokoyama T., Miyake Y., Sakamoto N., Inaba Y., et al. Nutritional Status and Risk of Amyotrophic Lateral Sclerosis in Japan. Amyotroph. Lateral Scler. 2007;8:300&#x2013;304. doi: 10.1080/17482960701472249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701472249</ArticleId><ArticleId IdType="pubmed">17852010</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink J.H., Kalmijn S., Groeneveld G.J., Wunderink W., Koster A., de Vries J.H.M., van der Luyt J., Wokke J.H.J., Van den Berg L.H. Intake of Polyunsaturated Fatty Acids and Vitamin E Reduces the Risk of Developing Amyotrophic Lateral Sclerosis. J. Neurol. Neurosurg. Psychiatry. 2007;78:367&#x2013;371. doi: 10.1136/jnnp.2005.083378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.083378</ArticleId><ArticleId IdType="pmc">PMC2077791</ArticleId><ArticleId IdType="pubmed">16648143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascherio A., Weisskopf M.G., O&#x2019;reilly E.J., Jacobs E.J., McCullough M.L., Calle E.E., Cudkowicz M., Thun M.J. Vitamin E Intake and Risk of Amyotrophic Lateral Sclerosis. Ann. Neurol. 2005;57:104&#x2013;110. doi: 10.1002/ana.20316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20316</ArticleId><ArticleId IdType="pubmed">15529299</ArticleId></ArticleIdList></Reference><Reference><Citation>Longnecker M.P., Kamel F., Umbach D.M., Munsat T.L., Shefner J.M., Lansdell L.W., Sandler D.P. Dietary Intake of Calcium, Magnesium and Antioxidants in Relation to Risk of Amyotrophic Lateral Sclerosis. Neuroepidemiology. 2000;19:210&#x2013;216. doi: 10.1159/000026258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000026258</ArticleId><ArticleId IdType="pubmed">10859501</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto K., Kihira T., Kobashi G., Washio M., Sasaki S., Yokoyama T., Miyake Y., Sakamoto N., Inaba Y., Nagai M. Fruit and Vegetable Intake and Risk of Amyotrophic Lateral Sclerosis in Japan. Neuroepidemiology. 2009;32:251&#x2013;256. doi: 10.1159/000201563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000201563</ArticleId><ArticleId IdType="pubmed">19209004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., O&#x2019;Reilly &#xc9;.J., Weisskopf M.G., Logroscino G., McCullough M.L., Schatzkin A., Kolonel L.N., Ascherio A. Vitamin E Intake and Risk of Amyotrophic Lateral Sclerosis: A Pooled Analysis of Data from 5 Prospective Cohort Studies. Am. J. Epidemiol. 2011;173:595&#x2013;602. doi: 10.1093/aje/kwq416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq416</ArticleId><ArticleId IdType="pmc">PMC3105261</ArticleId><ArticleId IdType="pubmed">21335424</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K.C., O&#x2019;Reilly &#xc9;.J., Fondell E., Falcone G.J., McCullough M.L., Park Y., Kolonel L.N., Ascherio A. Intakes of Vitamin C and Carotenoids and Risk of Amyotrophic Lateral Sclerosis: Pooled Results from 5 Cohort Studies. Ann. Neurol. 2013;73:236&#x2013;245. doi: 10.1002/ana.23820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23820</ArticleId><ArticleId IdType="pmc">PMC3608702</ArticleId><ArticleId IdType="pubmed">23362045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fondell E., O&#x2019;Reilly E.J., Fitzgerald K.C., Falcone G.J., McCullough M.L., Park Y., Kolonel L.N., Ascherio A. Magnesium Intake and Risk of Amyotrophic Lateral Sclerosis: Results from Five Large Cohort Studies. Amyotroph. Lateral Scler. Front. Degener. 2013;14:356&#x2013;361. doi: 10.3109/21678421.2013.803577.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.803577</ArticleId><ArticleId IdType="pmc">PMC3743429</ArticleId><ArticleId IdType="pubmed">23777266</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieves J.W., Gennings C., Factor-Litvak P., Hupf J., Singleton J., Sharf V., Oskarsson B., Fernandes Filho J.A.M., Sorenson E.J., D&#x2019;Amico E., et al. Association between Dietary Intake and Function in Amyotrophic Lateral Sclerosis. JAMA Neurol. 2016;73:1425&#x2013;1432. doi: 10.1001/jamaneurol.2016.3401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.3401</ArticleId><ArticleId IdType="pmc">PMC5370581</ArticleId><ArticleId IdType="pubmed">27775751</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B., Jin Y., Kim S.H., Park Y. Association between Macronutrient Intake and Amyotrophic Lateral Sclerosis Prognosis. Nutr. Neurosci. 2020;23:8&#x2013;15. doi: 10.1080/1028415X.2018.1466459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2018.1466459</ArticleId><ArticleId IdType="pubmed">29690822</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock C.L., Jacob R.A., Bowen P.E. Update on the Biological Characteristics of the Antioxidant Micronutrients: Vitamin C, Vitamin E, and the Carotenoids. J. Am. Diet. Assoc. 1996;96:693&#x2013;702; quiz 703. doi: 10.1016/S0002-8223(96)00190-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-8223(96)00190-3</ArticleId><ArticleId IdType="pubmed">8675913</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Shaw P.J. Oxidative Stress in ALS: Key Role in Motor Neuron Injury and Therapeutic Target. Free Radic. Biol. Med. 2010;48:629&#x2013;641. doi: 10.1016/j.freeradbiomed.2009.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico E., Factor-Litvak P., Santella R.M., Mitsumoto H. Clinical Perspective on Oxidative Stress in Sporadic Amyotrophic Lateral Sclerosis. Free Radic. Biol. Med. 2013;65:509&#x2013;527. doi: 10.1016/j.freeradbiomed.2013.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.06.029</ArticleId><ArticleId IdType="pmc">PMC3859834</ArticleId><ArticleId IdType="pubmed">23797033</ArticleId></ArticleIdList></Reference><Reference><Citation>Tourniaire F., Gouranton E., von Lintig J., Keijer J., Bonet M.L., Amengual J., Lietz G., Landrier J.-F. Beta-Carotene Conversion Products and Their Effects on Adipose Tissue. Genes Nutr. 2009;4:179&#x2013;187. doi: 10.1007/s12263-009-0128-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12263-009-0128-3</ArticleId><ArticleId IdType="pmc">PMC2745744</ArticleId><ArticleId IdType="pubmed">19557453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>